Literature DB >> 18538664

Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.

Jung Hyun Boo1, Ji Hoon Sohn, Ji Eun Kim, Hyundong Song, Inhee Mook-Jung.   

Abstract

Beta amyloid peptide is generated from amyloid precursor protein (APP) by proteolytic cleavage of beta- and gamma-secretases, and plays a critical role in the pathogenesis of Alzheimer's disease. Since gamma-secretase cleaves several proteins including APP and Notch in a number of cell types, it is important to understand the conditions determining gamma-secretase substrate specificity. In the present study, inhibition of Rac1 attenuated gamma-secretase activity for APP, resulting in decreased production of the APP intracellular domain but accumulated C-terminal fragments (APP-CTF). In contrast, Rac1 inhibitor, NSC23766 increased production of the Notch1 intracellular domain but slightly decreased the ectodomain-shed form of Notch1 (NotchDeltaE). To elucidate the mechanism underlying these observations, we performed co-immunoprecipitation experiments to analyze the interaction between Rac1 and presenilin1 (PS1), a component of the gamma-secretase complex. Inhibition of Rac1 enhanced its interaction with PS1. Under the same condition, PS1 interacted more strongly with NotchDeltaE than with APP-CTF. Our results suggested that PS1 determines the preferred substrate for gamma-secretase between APP and Notch1, depending on the activation status of Rac1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538664     DOI: 10.1016/j.bbrc.2008.05.153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Protein prenylation and synaptic plasticity: implications for Alzheimer's disease.

Authors:  David A Hottman; Ling Li
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

Review 2.  The potential role of rho GTPases in Alzheimer's disease pathogenesis.

Authors:  Silvia Bolognin; Erika Lorenzetto; Giovanni Diana; Mario Buffelli
Journal:  Mol Neurobiol       Date:  2014-01-23       Impact factor: 5.590

Review 3.  Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Authors:  Roger Lefort
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

4.  Ligand-dependent activation of EphA4 signaling regulates the proteolysis of amyloid precursor protein through a Lyn-mediated pathway.

Authors:  Wei-Bin Lai; Bo-Jeng Wang; Ming-Kuan Hu; Wen-Ming Hsu; Guor Mour Her; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2013-11-12       Impact factor: 5.590

5.  Farnesyltransferase haplodeficiency reduces neuropathology and rescues cognitive function in a mouse model of Alzheimer disease.

Authors:  Shaowu Cheng; Dongfeng Cao; David A Hottman; LiLian Yuan; Martin O Bergo; Ling Li
Journal:  J Biol Chem       Date:  2013-10-17       Impact factor: 5.157

6.  Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy.

Authors:  F Zeidán-Chuliá; B-H N de Oliveira; A B Salmina; M F Casanova; D P Gelain; M Noda; A Verkhratsky; J C F Moreira
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

Review 7.  Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration.

Authors:  Trisha R Stankiewicz; Daniel A Linseman
Journal:  Front Cell Neurosci       Date:  2014-10-07       Impact factor: 5.505

8.  Molecular profiling reveals diversity of stress signal transduction cascades in highly penetrant Alzheimer's disease human skin fibroblasts.

Authors:  Graziella Mendonsa; Justyna Dobrowolska; Angela Lin; Pooja Vijairania; Y-J I Jong; Nancy L Baenziger
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

9.  The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma.

Authors:  Qi Zhou; Yafeng Wang; Baogang Peng; Lijian Liang; Jiaping Li
Journal:  BMC Cancer       Date:  2013-05-20       Impact factor: 4.430

10.  Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.

Authors:  Ursula S Sandau; Jack T Wiedrick; Sierra J Smith; Trevor J McFarland; Theresa A Lusardi; Babett Lind; Christina A Harrington; Jodi A Lapidus; Douglas R Galasko; Joseph F Quinn; Julie A Saugstad
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.